Melanomas caused by sun exposure have been matched with targeted treatments and immunotherapies, in many cases dramatically extending patients’ lives. However, there are other kinds of melanoma not related to sun exposure and because they are caused by different genetic changes, they are not susceptible to the same targeted treatments. This often leaves patients...
Tag: <span>Lung cancer</span>
Post
Terry Fox research team’s model for detecting lung cancer saves lives, is a world leader
Vancouver, BC – A pan-Canadian team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with significantly greater accuracy than other leading models. This Terry Fox Research Institute study suggests the team’s innovative approach could be considered for use in lung cancer screening programs both in Canada and...
Post
Possible new immune therapy target in lung cancer
Fluorescence microscopy images of blood vessels supported by perivascular cells. The top row shows vessels with perivascular cells from normal lung tissue compared to vessels supported by tumor-derived perivascular cells (bottom row). The …more A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors...
Post
Immunotherapy for lung cancer: What you need to know
Immunotherapy, also known as biologic therapy, may benefit people fighting certain kinds of lung cancer. This treatment option uses medicines to stimulate the body’s immune system so that it can fight the cancer cells more effectively. Immunotherapy has changed the way doctors treat many types of cancer, including lung cancer. In this article, we look at how immunotherapy...
Post
Anti-inflammatory therapy cuts risk of lung cancer
In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given researchers a unique opportunity: to explore the effectiveness of giving a drug to patients before cancer emerges. At the European Society of Cardiology meeting, Paul M. Ridker, MD, director of the...
Post
New strategy to treat aggressive lung cancer
Research conducted by a team of Norton Thoracic Institute scientists on a novel therapeutic avenue for an aggressive and difficult to treat subgroup of lung cancer was published in the August 15, 2017 issue of Cancer Research. The research was led by assistant professors at Norton Thoracic Institute, Timothy Whitsett, PhD, and Landon Inge, PhD. The...
Post
How a chemo drug can help cancer spread from the breast to the lungs
COLUMBUS, Ohio -The very same treatment that thwarts breast cancer has a dark side—it can fuel the spread of the disease to the lungs. Researchers at The Ohio State University studied the cascade of events that lead to metastatic cancer and found clues to why it happens, opening up the possibility of one day interfering with the...
Post
Breaking the genetic resistance of lung cancer and melanoma
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance to targeted therapies. Dr Luciano Martelotto, from the Monash University Faculty of Medicine, and his collaborators Dr Piro Lito and Yaohua Xue...
Post
Some lung cancer patients benefit from immunotherapy even after disease progression
Some advanced lung cancer patients benefit from immunotherapy even after the disease has progressed as evaluated by standard criteria, according to research presented at the European Lung Cancer Conference (ELCC).1 The findings pave the way for certain patients to continue treatment if the disease is not progressing according to new, more specific, criteria. The Response Evaluation...
Post
Researchers identify immunotherapy targets in early-stage lung cancer
Lung CA seen on CXR. Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell. Researchers...